| # | Drug | Count |
|---|---|---|
| 0 | ABATACEPT | 26 |
| 1 | ADALIMUMAB | 26 |
| 2 | BARICITINIB | 26 |
| 3 | RITUXIMAB | 26 |
| 4 | TOCILIZUMAB | 26 |
| 5 | UPADACITINIB | 26 |
| 6 | ADALIMUMAB-AATY | 25 |
| 7 | ADALIMUMAB-ADAZ | 24 |
| 8 | ADALIMUMAB-FKJP | 24 |
| 9 | TACROLIMUS | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 26 | 0.0085 |
| 1 | ETHIODIZED OIL | 1 | 0.0008 |
| 2 | ADALIMUMAB-FKJP | 24 | 0.0005 |
| 3 | ADALIMUMAB-AATY | 25 | 0.0005 |
| 4 | ADALIMUMAB-ADAZ | 24 | 0.0004 |
| 5 | CAPIVASERTIB | 1 | 0.0003 |
| 6 | INSULIN GLARGINE-YFGN | 7 | 0.0003 |
| 7 | UPADACITINIB | 26 | 0.0003 |
| 8 | CILTACABTAGENE AUTOLEUCEL | 2 | 0.0003 |
| 9 | TOCILIZUMAB | 26 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Receptor Antagonist [EPC] | 26 | 0.0002 |
| 1 | Selective T Cell Costimulation Modulator [EPC] | 26 | 0.0002 |
| 2 | Janus Kinase Inhibitor [EPC] | 26 | 0.0002 |
| 3 | Prostacyclin Receptor Agonist [EPC] | 3 | 0.0001 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 26 | 0.0001 |
| 5 | Purine Antimetabolite [EPC] | 7 | 0.0001 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 7 | 0.0001 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 8 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 9 | Alkaloid [EPC] | 1 | 0.0000 |